RNASEH2A


Summary: The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.[provided by RefSeq, Aug 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DNA REPAIR

GO terms in RNASEH2A


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0003723 RNA binding
MF IBA GO:0004523 RNA-DNA hybrid ribonuclease activity
MF IDA GO:0004523 RNA-DNA hybrid ribonuclease activity
MF TAS GO:0004540 ribonuclease activity
MF IEA GO:0046872 metal ion binding
CC IDA GO:0005654 nucleoplasm
Showing 1 to 6 of 15 rows rows per page

Gene expression in normal tissue: RNASEH2A

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in RNASEH2A


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa03030 DNA replication - Homo sapiens (human)
Showing 1 to 1 of 1 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD888 Compound 44 3
iGMDRD74 Idarubicin 3
iGMDRD872 BRD7137 3
iGMDRD100 Zebularine 2
Showing 1 to 4 of 25 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in RNASEH2A

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​